South Africa has the world’s largest population of people living with HIV, which both heightens the risk of anal cancers and their severity. However, neither the collection of data nor the efforts for prevention and screening are in line with the likely impact. Experts say significant change is needed, reports Elna Schütz.
An HIV prevention jab that provides six months of protection at a time was given the green light by South Africa’s medicines regulator. The approval helps to clear the way for a limited public sector rollout of the “game-changing” shot set to start in April 2026.
A landmark ruling from the Supreme Court of Appeal means specially trained pharmacists will soon be allowed to dispense antiretrovirals without a doctor’s script. Pharmacists with the required training will need special permits from the director general of health. While no pharmacists yet hold these permits, Catherine Tomlinson reports that they may be able to start applying for them as soon as next month.
Ritshidze, South Africa’s powerhouse community-led healthcare monitor, is on the brink of shutting down. Experts warn its collapse could unravel years of progress in our clinics – just as worrying new data points to a decline in HIV services.
A child-friendly formulation of the antiretroviral drug dolutegravir was first included in the country’s HIV treatment guidelines in 2023. New estimates suggest that most children aged one to four living with HIV have now been switched to the drug, reports Elri Voigt.
The obesity epidemic will hit South Africa hard on top of our high HIV burden, but advocate researcher and scientist Dr Nomathemba Chandiwana says she is ready to fight back harder. She speaks to Ufrieda Ho about her journey from working in state hospitals to transitioning into obesity medicine, and her move to Cape Town.
In response to US funding cuts for South African health services and research projects, National Treasury has provided the National Department of Health with hundreds of millions of rands in emergency funds. Spotlight and GroundUp look at how precisely the government intends to spend this money.
Spotlight and GroundUp published a two-part exposé showing how US aid cuts led to the deaths of children in Mozambique. Here, Jesse Copelyn considers what led to this tragedy and who should bear responsibility for it.
South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor Francois Venter.
South Africa still lacks an action plan after the withdrawal of US aid for HIV and related health services. But when funds do arrive, how will they be managed? Russell Rensburg suggests the answer may lie in the District Health Programme Grant.
After the abrupt termination of American aid, the health system in central Mozambique descended into chaos. In part two of this special series, Spotlight and GroundUp describe how the funding cuts affected hospitals, where key staff were dismissed and deliveries of new medicines were halted. In the ensuing turmoil, children died.
In Mozambique, the health system is overwhelmingly built on US money. When the Trump administration instantly pulled much of this funding without warning, disease and death spread. Spotlight and GroundUp visited one of the worst affected regions to describe the human toll.
